Yichang Tianren Pharmaceutical Co., Ltd. was established in 2004. It is a holding subsidiary of Yichang Renfu Pharmaceutical, focusing on the research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The company has 5 GMP production lines with a total reaction volume of more than 80 cubic meters, which can meet various needs from clinical to commercial production. The products cover areas such as antiviral, anti-ED, and anti-infection. The leading products include valacyclovir hydrochloride, tadalafil and abidor. The company has won many honors, including "High-tech Enterprise", "Hubei Enterprise Technology Center" and "Hubei Province Specialized and New Little Giant". In the future, the company will use the GMP management model to strive to create differentiated raw material products, expand CMO and CDMO businesses, and promote sustainable development.